Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

OTC Markets Group Welcomes Covalon Technologies to OTCQX

OTC Markets Group Inc.
Posted on: 18 Sep 17
OTC Markets Group Welcomes Covalon Technologies to OTCQX

PR Newswire

NEW YORK, Sept. 18, 2017

NEW YORK, Sept. 18, 2017 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Covalon Technologies Ltd. (TSX-V: COV; OTCQX: CVALF), a researcher, developer, manufacturer, and marketer of patent protected medical products, has qualified to trade on the OTCQX® Best Market. Covalon Technologies upgraded to OTCQX from the Pink® market.

Covalon Technologies begins trading today on OTCQX under the symbol "CVALF."  U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

"Trading on OTCQX will enable Covalon Technologies to provide a transparent trading and information experience for its U.S. investors as it focuses on growing its business and delivering long-term shareholder value," said Jason Paltrowitz, Executive Vice President of OTC Markets Group. "We welcome Covalon to the OTCQX market and wish the company growth and success."

 "We are seeing increasing investor interest from the United States and having our shares also trade on OTCQX will help increase shareholder liquidity," said Danny Brannagan, Chief Financial Officer of Covalon Technologies Ltd. "Our strong growth in revenue and profits combined with our growing presence in global healthcare markets makes Covalon an attractive company for the investment community in the United States. OTCQX provides Covalon with exposure to both institutional and retail investors through major online and full-service brokerage firms, helping us to  continue to drive shareholder value for existing shareholders and provide opportunities for future shareholders."

Covalon Technologies was sponsored for OTCQX by McMillan LLP, a qualified third-party firm responsible for providing guidance on OTCQX requirements and recommending membership. 

About Covalon Technologies
Covalon Technologies Ltd. researches, develops and commercializes new healthcare technologies that help save lives around the world. Covalon's patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Covalon's technologies are used to prevent, detect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility. To learn more about Covalon, visit our website at www.covalon.com

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global securities.  Through OTC Link® ATS, we connect a diverse network of broker-dealers that provide liquidity and execution services.  We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS. Subscribe to the OTC Markets RSS Feed

Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, media@otcmarkets.com

View original content:http://www.prnewswire.com/news-releases/otc-markets-group-welcomes-covalon-technologies-to-otcqx-300520795.html

SOURCE OTC Markets Group Inc.

PR Newswire
www.prnewswire.com

Last updated on: 18/09/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.